Table 1 Demographic data of 50 iNPH patients at baseline and 50 healthy controls (HC)

Sex (m/f)

34/16

34/16ns

Age (median, Q1-Q3)

73 (69–78)

73 (71–80)ns

MMSE (median, Q1-Q3)

25 (21–28)

29 (29–30)***

BMI (median, Q1-Q3)

28 (25–31)

25 (23–27)**

Diabetes (yes/no)

28% (14/35)

10% (5/45)*

Hypertension (yes/no)

60% (30/19)

38% (19/31)*

Symptom duration, months

36 (24–66)

Time to follow-up, months

9 (8–11)